Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing is measured in units rather than milligrams, which can create confusion when patients compare prescriptions or track their treatment progression. Understanding the relationship between units and milligrams—and how this translates to real weight loss outcomes—is essential for anyone starting a GLP-1 therapy program. PlexusDx provides transparent dosing guidance so patients can feel confident about their personalized injection protocols.
Converting Semaglutide Units to Milligrams
Semaglutide concentration in standard clinical formulations is 1 mg per 1 mL of solution, which means 1 unit does not directly equal a fixed milligram amount—instead, the relationship depends on the pen or vial concentration your pharmacy dispenses. Most compounded semaglutide injections from licensed 503A compounding pharmacies use a standard 2.4 mg/3 mL concentration, making the math straightforward: each unit represents approximately 0.08 mg of active semaglutide. This means 20 units of semaglutide equals roughly 1.6 mg of the active compound.
The unit-to-milligram conversion matters because it clarifies what dose strength you're actually receiving at each treatment stage. Early treatment phases typically start patients at lower unit amounts (2.4 units or 0.2 mg) and increase gradually every 4 weeks to allow the body to adjust and minimize nausea. Knowing that your 20-unit injection contains 1.6 mg helps you understand how your dose compares to published clinical trial data, where most patients achieved significant weight loss at doses ranging from 1.0 to 2.4 mg per week.
Semaglutide Dosing Schedule and Weight Loss Outcomes
Clinical evidence from the STEP trials showed that participants receiving 2.4 mg of semaglutide weekly lost an average of 15% of their body weight over 68 weeks, compared to less than 3% in the placebo group. The standard escalation protocol moves patients through four dose tiers: 0.25 mg, 0.5 mg, 1.0 mg, and the target maintenance dose of 2.4 mg. At PlexusDx, your dose may need to go up during this four-week titration phase, but your monthly price remains flat—patients pay the same rate whether they inject 2.4 units or 20 units.
Most patients reach meaningful weight loss momentum once they stabilize at or near the 1.0 to 2.4 mg weekly range, which typically corresponds to 12 to 20 units per injection. Adherence to this dosing schedule matters more than jumping to higher doses rapidly; slower escalation reduces gastrointestinal side effects and allows metabolism to adjust. PlexusDx monitors patient progress during monthly check-ins to confirm dose adjustments are working and to rule out other factors that might slow results.
Why Compounded Semaglutide Offers Dosing Flexibility
Licensed 503A compounding pharmacies can prepare semaglutide at multiple concentrations and volumes, giving patients and providers flexibility that pre-filled pens do not. While brand-name Ozempic and Wegovy come in fixed-dose increments, compounded semaglutide from PlexusDx can be customized to match each patient's tolerance, weight loss phase, and treatment goals. This flexibility means your provider can prescribe exactly 20 units or any intermediate dose without wasting unused medication or jumping to the next commercial pen strength.
Compounding also supports microdosing protocols for patients who experience side effects at standard doses—a strategy sometimes called tirzepatide-semaglutide blending or stepwise escalation. PlexusDx's Microdose GLP-1 Protocol ($129/mo flat) allows patients to start at lower unit amounts and advance at their own pace while maintaining affordability. All compounded medications come from licensed 503A compounding pharmacies that follow strict FDA quality and sterility standards, ensuring that every 20-unit injection contains precisely the labeled dose.
Personalized Dosing Through Genetic Insight
Individual genetic variation affects how quickly semaglutide works and what dose produces the best weight loss with fewer side effects. PlexusDx's Precision Peptide Genetic Test identifies key variants in the GLP1R, GIPR, FTO, and MC4R genes that influence your metabolic response to GLP-1 therapy. Patients with specific FTO rs9939609 genotypes, for example, may see accelerated early weight loss but require careful dose titration, while others with favorable GLP1R rs6923761 variants may achieve results at lower unit amounts.
Understanding your peptide pathway genetics helps your PlexusDx provider decide whether to escalate to 20 units quickly or hold at a lower dose longer to maximize tolerability and adherence. The Precision Peptide Genetic Test maps 14 pathways and 150+ genetic insights across 49 peptides, providing a roadmap for your personalized treatment plan. After your first month of semaglutide injections, adding the genetic test ($99 add-on) allows your provider to refine dosing strategy based on your unique biology, not just standard protocols.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many milligrams is 20 units of semaglutide exactly?
20 units of semaglutide equals approximately 1.6 mg of active compound in standard compounded formulations (using the 2.4 mg/3 mL concentration common from licensed 503A compounding pharmacies). This dose is in the therapeutic range used in clinical weight loss trials and is typically reached after completing the four-week titration phase.
Will my price increase when my semaglutide dose goes from 5 units to 20 units?
No. PlexusDx's pricing model keeps your monthly rate flat regardless of dose escalation—whether you inject 2.4 units or 20 units, you pay the same rate ($149/mo for Compounded Semaglutide Injection). Your dose may need to go up; your price won't.
What clinical evidence supports 20 units (1.6 mg) of semaglutide for weight loss?
The STEP trial program demonstrated that semaglutide doses from 1.0 mg to 2.4 mg weekly produce dose-dependent weight loss, with participants achieving 10–15% body weight reduction over 68 weeks. Most patients reach stabilization at doses between 1.0 and 2.4 mg per week (12 to 20 units), making this range evidence-backed for sustained results.
Is compounded semaglutide at 20 units safe compared to brand-name versions?
Yes. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies that follow FDA quality and sterility standards. Compounded injections are not FDA-approved as a drug product, but the active pharmaceutical ingredient and preparation methods meet the same safety criteria as brand medications, with the added benefit of dose customization.
Could my genetic makeup affect whether 20 units is the right dose for me?
Absolutely. Your GLP1R, GIPR, FTO, and MC4R genetic variants influence how rapidly semaglutide takes effect and which dose produces optimal weight loss with minimal side effects. PlexusDx's Precision Peptide Genetic Test identifies these pathways so your provider can personalize dosing—some patients thrive at 20 units, while others reach goals at lower doses depending on their genetic profile.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Prevent Nausea on GLP-1 Medications: A Comprehensive Guide
How Long Can You Take Ozempic for Weight Loss In 2026?